Study Comparing One Versus Two Cortisone Injections for Trigger Finger
A Prospective, Randomized Study Comparing One vs. Two Cortisone Injections for Trigger Finger
1 other identifier
interventional
392
1 country
7
Brief Summary
Trigger finger, also known as stenosing tenosynovitis, is a painful condition that can cause discomfort and disability. Many physicians choose to locally inject cortisone into the infected finger although there is no current consensus as to how many injections are needed to achieve maximum relief. This study will be a prospective, randomized study to compare one versus two injections for the treatment of trigger finger.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
7 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2009
CompletedFirst Submitted
Initial submission to the registry
July 31, 2009
CompletedFirst Posted
Study publicly available on registry
August 4, 2009
CompletedFebruary 12, 2014
February 1, 2014
July 31, 2009
February 10, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
To determine if there is a difference in the incidence of pain, stiffness, clicking or locking at 6 months following final injection
Secondary Outcomes (3)
To evaluate treatment response among diabetic patients
To evaluate treatment response between thumbs and fingers
To evaluate treatment response between nodular versus diffuse tenosynovitis
Study Arms (2)
One injection
ACTIVE COMPARATORTwo Injections
ACTIVE COMPARATORInterventions
Patients in this arm will receive one cortisone injection for the treatment of his/her symptoms
Subjects randomized to this treatment will receive two cortisone injections, 4-6 weeks apart
Eligibility Criteria
You may qualify if:
- Subject is greater than 18 years of age, presenting with stenosing tenosynovitis.
- Subject is willing and able to provide informed consent.
You may not qualify if:
- Patients who have previously undergone surgery for the treatment of trigger finger.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (7)
Rothman Institute: Egg Harbor Township Location
Egg Harbor, New Jersey, 08234, United States
Rothman Institute: Manahawkin location
Manahawkin, New Jersey, 08050, United States
Rothman Institute: Vorhees location
Vorhees, New Jersey, 08043, United States
Rothman Institute: Media location
Media, Pennsylvania, 19063, United States
Rothman Institute Center City Location
Philadelphia, Pennsylvania, 19107, United States
Rothman Institute, South Philadelphia Location
Philadelphia, Pennsylvania, 19145, United States
Rothman Institute, Northeast Philadelphia location
Philadelphia, Pennsylvania, 19152, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Charles Leinberry, MD
Rothman Institute
- PRINCIPAL INVESTIGATOR
Pedro Beredjiklian, MD
Rothman Institute
- PRINCIPAL INVESTIGATOR
Emran Sheikh, MD
Rothman Institute
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
July 31, 2009
First Posted
August 4, 2009
Study Start
May 1, 2009
Last Updated
February 12, 2014
Record last verified: 2014-02